Pharmaceuticals

Novartis plans to acquire Mariana Oncology to strengthen radioligand therapy pipeline

bexib
By bexib 0 Min Read

The agreement includes a number of radioligand therapies targeting solid tumors such as breast, prostate and lung cancer.

You Might Also Like

Francis Crick scientists have revealed how cells ‘sound the alarm’ when they are damaged or infected.

TC Biopharm Announces Mpox Therapeutic Research Plan

Apollo and Oxford University collaborate on drug discovery and development

Despite admissions committee rejection, Lycos CEO sees potential for MDMA drug

As Big Pharma Bet Bigger on ADCs, Where Does the Field Go From Here?

Share This Article
Previous Article Comparison of ChatGPT and Gemini for SEO tasks
Next Article Do you want to buy a new home? Discover interior elements that prioritize the health of your family
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Cap One and Discover to complete acquisition in ‘early 2025’
Banking
52% of executives say they plan to use agents
Banking
Blueprint for 2025: Stronger trade policy
Manufacturing
China’s seapower expands as US shipyards decline
Manufacturing